RubrYc Therapeutics Discovery-Stage Pipeline
RubrYc’s pipeline of products includes several proprietary therapeutic antibody programs targeting unique epitopes for oncology and immunology indications.
RTX-001 T-Cell Checkpoint Antagonist
Immuno-Oncology
RTX-002 T-Cell Checkpoint Agonist
Autoimmune
RTX-003 Tumor-targeted T-Cell Activation
Immuno-Oncology
RTX-004 Macrophage Targeting
Autoimmune